Literature DB >> 3903643

Thiamine response in maple syrup urine disease.

P M Fernhoff, D Lubitz, D J Danner, P P Dembure, H P Schwartz, R Hillman, D M Bier, L J Elsas.   

Abstract

We measured the biochemical response for four patients with maple syrup disease to pharmacologic doses of thiamine, and correlated their response to their branched chain alpha-ketoacid dehydrogenase activity. We observed a linear correlation between the concentrations of each plasma branched-chain amino acid and its corresponding ketoacid analogue. In addition, the renal tubular reabsorption of branched-chain amino and ketoacids was nearly complete within these physiologic concentrations. Three children responded to thiamine therapy with a reduction in concentration of plasma and urinary branched-chain amino and ketoacids. Each responder had at least 5% activity for branched chain alpha-ketoacid dehydrogenase in their mononuclear blood cells and in whole cell fibroblasts from cultured skin when compared to the activity in normal control cells. We propose that each child with maple syrup urine disease be assessed for their response to thiamine by quantifying the concentration of branched-chain amino acids in plasma before and after vitamin supplementation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903643     DOI: 10.1203/00006450-198510000-00012

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Orthomolecular therapy: its history and applicability to psychiatric disorders.

Authors:  F J Menolascino; J Y Donaldson; T F Gallagher; C J Golden; J E Wilson
Journal:  Child Psychiatry Hum Dev       Date:  1988

Review 2.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Gene preference in maple syrup urine disease.

Authors:  M M Nellis; D J Danner
Journal:  Am J Hum Genet       Date:  2000-12-07       Impact factor: 11.025

4.  Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.

Authors:  P Schadewaldt; H W Hammen; A C Ott; U Wendel
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

Review 5.  Emergency management of inherited metabolic diseases.

Authors:  V Prietsch; M Lindner; J Zschocke; W L Nyhan; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

6.  A Patient with MSUD: Acute Management with Sodium Phenylacetate/Sodium Benzoate and Sodium Phenylbutyrate.

Authors:  Melis Köse; Ebru Canda; Mehtap Kagnici; Sema Kalkan Uçar; Mahmut Çoker
Journal:  Case Rep Pediatr       Date:  2017-05-15

7.  Genomic and biochemical analysis of repeatedly observed variants in DBT in individuals with maple syrup urine disease of Central American ancestry.

Authors:  Charles J Billington; Kimberly A Chapman; Eyby Leon; Beatrix W Meltzer; Seth I Berger; Matthew Olson; Robert A Figler; Steve A Hoang; Cui Wanxing; Brian R Wamhoff; M Sol Collado; Kristina Cusmano-Ozog
Journal:  Am J Med Genet A       Date:  2022-07-07       Impact factor: 2.578

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.